Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Abstract Background Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its l...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2021-05-01
|
| Cyfres: | BMC Pharmacology and Toxicology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s40360-021-00495-w |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
